These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients. Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133 [TBL] [Abstract][Full Text] [Related]
29. The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study. Elhelw O; Ragavan S; Majeed W; Alkhaffaf B; Mohammed N; Senapati S; Ammori BJ; Robinson JA; Syed AA Surgeon; 2024 Feb; 22(1):e26-e33. PubMed ID: 37567846 [TBL] [Abstract][Full Text] [Related]
30. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. Corey KE; Misdraji J; Gelrud L; King LY; Zheng H; Malhotra A; Chung RT Dig Dis Sci; 2015 Aug; 60(8):2523-8. PubMed ID: 25840922 [TBL] [Abstract][Full Text] [Related]
31. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study. Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336 [TBL] [Abstract][Full Text] [Related]
32. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis. Chatterjee A; Basu A; Das K; Singh P; Mondal D; Bhattacharya B; Roychoudhury S; Majumder PP; Chowdhury A; Basu P Ann Hepatol; 2020; 19(5):472-481. PubMed ID: 32682086 [TBL] [Abstract][Full Text] [Related]
33. Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. Barbois S; Arvieux C; Leroy V; Reche F; Stürm N; Borel AL Surg Obes Relat Dis; 2017 Oct; 13(10):1780-1786. PubMed ID: 28935200 [TBL] [Abstract][Full Text] [Related]
34. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study. Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174 [TBL] [Abstract][Full Text] [Related]
35. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement. Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123 [TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Souto KP; Meinhardt NG; Ramos MJ; Ulbrich-Kulkzynski JM; Stein AT; Damin DC Surg Obes Relat Dis; 2018 Jan; 14(1):66-73. PubMed ID: 29104004 [TBL] [Abstract][Full Text] [Related]
37. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery. Udelsman BV; Corey KE; Lindvall C; Gee DW; Meireles OR; Hutter MM; Chang DC; Witkowski ER Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948 [TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in resolution of nonalcoholic fatty liver disease post bariatric surgery in adolescents. Bacha F; Gupta R; Jenkins TM; Brandt ML; Inge TH; Kleiner DE; Xanthakos SA; Surg Obes Relat Dis; 2024 Apr; 20(4):367-375. PubMed ID: 38155077 [TBL] [Abstract][Full Text] [Related]
39. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. Chaim FDM; Pascoal LB; Chaim FHM; Palma BB; Damázio TA; da Costa LBE; Carvalho R; Cazzo E; Gestic MA; Utrini MP; Milanski M; Chaim EA; Leal RF Sci Rep; 2020 May; 10(1):8496. PubMed ID: 32444690 [TBL] [Abstract][Full Text] [Related]
40. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery. Yuan X; Chen J; Cheng Q; Zhao Y; Zhang P; Shao X; Bi Y; Shi X; Ding Y; Sun X; Xue B BMC Gastroenterol; 2018 Oct; 18(1):147. PubMed ID: 30285651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]